Finance

Lists
ABL:ETR
Abbott Laboratories
€98.52
+1.42%
(+1.38) 1D
Nov 3, 5:35:38 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
€98.62
High
€98.66
Low
€97.08
Mkt. cap
189.30B
Avg. vol.
623.00
Volume
3.07K
52-wk high
€113.36
52-wk low
€70.10
No. of employees
115K
Open
€98.62
High
€98.66
Low
€97.08
Mkt. cap
189.30B
Avg. vol.
623.00
Volume
3.07K
52-wk high
€113.36
52-wk low
€70.10
No. of employees
115K
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115K
Founded1888
HeadquartersChicago, Illinois, United States
SectorMedical device
Industry-
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
11.46B
11.16B
12.59B
13.01B
Cost of goods sold
4.91B
4.89B
5.32B
5.59B
Cost of revenue
4.91B
4.89B
5.32B
5.59B
Research and development expenses
720.00M
767.00M
892.00M
908.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.93B
3.58B
3.87B
4.20B
Operating expense
4.07B
4.77B
5.42B
5.95B
Total operating expenses
8.98B
9.66B
10.74B
11.54B
Operating income
2.48B
1.50B
1.85B
1.48B
Other non operating income
-15.00M
-
-25.00M
173.00M
EBT including unusual items
2.36B
1.45B
1.52B
1.23B
EBT excluding unusual items
2.44B
1.45B
1.52B
1.36B
Income tax expense
582.00M
372.00M
596.00M
311.00M
Effective tax rate
24.68%
25.67%
39.11%
25.26%
Other operating expenses
-
-
-
-
Net income
1.78B
1.08B
928.00M
920.00M
Net profit margin
15.50%
9.65%
7.37%
7.07%
Earnings per share
1.50
1.15
1.31
1.42
Interest and investment income
78.00M
106.00M
52.00M
-
Interest expense
-120.00M
-174.00M
-351.00M
-297.00M
Net interest expenses
-42.00M
-68.00M
-299.00M
-297.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.27B
2.31B
2.91B
2.54B
Gain or loss from assets sale
65.00M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps